These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
519 related articles for article (PubMed ID: 18061886)
1. Status of terpenes as skin penetration enhancers. Aqil M; Ahad A; Sultana Y; Ali A Drug Discov Today; 2007 Dec; 12(23-24):1061-7. PubMed ID: 18061886 [TBL] [Abstract][Full Text] [Related]
2. Role of novel terpenes in transcutaneous permeation of valsartan: effectiveness and mechanism of action. Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M; Ali A Drug Dev Ind Pharm; 2011 May; 37(5):583-96. PubMed ID: 21469947 [TBL] [Abstract][Full Text] [Related]
3. Chemical penetration enhancers: a patent review. Ahad A; Aqil M; Kohli K; Chaudhary H; Sultana Y; Mujeeb M; Talegaonkar S Expert Opin Ther Pat; 2009 Jul; 19(7):969-88. PubMed ID: 19552513 [TBL] [Abstract][Full Text] [Related]
4. Natural Terpenes as Penetration Enhancers for Transdermal Drug Delivery. Chen J; Jiang QD; Chai YP; Zhang H; Peng P; Yang XX Molecules; 2016 Dec; 21(12):. PubMed ID: 27973428 [TBL] [Abstract][Full Text] [Related]
5. Penetration enhancers. Williams AC; Barry BW Adv Drug Deliv Rev; 2004 Mar; 56(5):603-18. PubMed ID: 15019749 [TBL] [Abstract][Full Text] [Related]
6. [Development and evaluation of terpene penetration enhancers]. Hua N; Liu W; Guo RC Zhongguo Zhong Yao Za Zhi; 2008 Dec; 33(24):2875-82. PubMed ID: 19294840 [TBL] [Abstract][Full Text] [Related]
7. Role of complexes formation between drugs and penetration enhancers in transdermal delivery. Drakulić BJ; Juranić IO; Erić S; Zloh M Int J Pharm; 2008 Nov; 363(1-2):40-9. PubMed ID: 18675333 [TBL] [Abstract][Full Text] [Related]
8. The effect of penetration enhancers on drug delivery through skin: a QSAR study. Ghafourian T; Zandasrar P; Hamishekar H; Nokhodchi A J Control Release; 2004 Sep; 99(1):113-25. PubMed ID: 15342185 [TBL] [Abstract][Full Text] [Related]
9. Recent advances in transdermal drug delivery. Subedi RK; Oh SY; Chun MK; Choi HK Arch Pharm Res; 2010 Mar; 33(3):339-51. PubMed ID: 20361297 [TBL] [Abstract][Full Text] [Related]
10. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations. Pfister WR; Hsieh DS Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148 [TBL] [Abstract][Full Text] [Related]
11. Effect of chemical enhancers on percutaneous absorption of daphnetin in isopropyl myristate vehicle across rat skin in vitro. Wen Z; Fang L; He Z Drug Deliv; 2009 May; 16(4):214-23. PubMed ID: 19280376 [TBL] [Abstract][Full Text] [Related]
12. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations. Pfister WR; Hsieh DS Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149 [TBL] [Abstract][Full Text] [Related]
13. Formulation development of transdermal dosage forms: quantitative structure-activity relationship model for predicting activities of terpenes that enhance drug penetration through human skin. Kang L; Yap CW; Lim PF; Chen YZ; Ho PC; Chan YW; Wong GP; Chan SY J Control Release; 2007 Jul; 120(3):211-9. PubMed ID: 17582639 [TBL] [Abstract][Full Text] [Related]
16. Skin absorption enhancers. Williams AC; Barry BW Crit Rev Ther Drug Carrier Syst; 1992; 9(3-4):305-53. PubMed ID: 1458546 [TBL] [Abstract][Full Text] [Related]
17. Enhanced transdermal delivery of loratadine from the EVA matrix. Cho CW; Choi JS; Kim SJ; Shin SC Drug Deliv; 2009 May; 16(4):230-5. PubMed ID: 19514983 [TBL] [Abstract][Full Text] [Related]
18. Limonene GP1/PG organogel as a vehicle in transdermal delivery of haloperidol. Lim PF; Liu XY; Kang L; Ho PC; Chan YW; Chan SY Int J Pharm; 2006 Mar; 311(1-2):157-64. PubMed ID: 16451823 [TBL] [Abstract][Full Text] [Related]
19. Transdermal delivery of contraceptives. Friend DR Crit Rev Ther Drug Carrier Syst; 1990; 7(2):149-86. PubMed ID: 2272099 [TBL] [Abstract][Full Text] [Related]
20. Biomaterials as novel penetration enhancers for transdermal and dermal drug delivery systems. Chen Y; Wang M; Fang L Drug Deliv; 2013; 20(5):199-209. PubMed ID: 23763451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]